Details werden geladen...
Novartis, Antares stars align in cancer deal that could top $1.9B - BioSpace
Novartis and Antares Therapeutics are shooting for the stars, launching a joint mission to develop small molecule oncology therapies.
Ähnliche Seiten
Jazz strikes new chord with AbCellera in T cell engager pact that could top $2.4B - BioSpace
https://www.biospace.com/deals/jazz-strikes-new-chord-with-abcellera-in-t-cell-engager-pact-that-could-top-2-4b
Novartis experimental actinium-based drug shows promise in prostate cancer treatment: Study - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-experimental-actinium-based-drug-shows-promise-in-prostate-cancer-treatment-study/articleshow/131422192.cmsNiowave, fresh from Novartis deal, starts building $75M radioisotope plant - BioSpace
https://www.biospace.com/business/niowave-fresh-from-novartis-deal-starts-building-75m-radioisotope-plantCan Revolution’s 'miracle' pancreatic cancer drug be topped? Immuneering, Actuate say yes - BioSpace
https://www.biospace.com/drug-development/can-revolutions-miracle-pancreatic-cancer-drug-be-topped-immuneering-actuate-say-yes
A “living drug” that could change the way we treat cancer - TEDMED
https://www.tedmed.com/talk/a-living-drug-that-could-change-the-way-we-treat-cancer/